Blood

1. ABRAMSON JS, Siddiqi T, Gordon LI, Lunning M, et al
   Five-year survival outcomes of lisocabtagene maraleucel in R/R LBCL from the TRANSCEND NHL 001 study.
   Blood. 2026;148:1388-1393.
   

   >> Share

   
   

   
   Eur J Haematol

2. ZHANG Q, Fang W, Liu Y
   Translational Insights From the Molecular Landscape to Precision Therapy in Peripheral T-Cell Lymphoma: Integrating Multi-Omics and Artificial Intelligence.
   Eur J Haematol. 2026 Sep 8. doi: 10.1111/ejh.70313.
   

   >> Share

   
   

   
   Haematologica

3. VALCARCEL B, Vasquez JF, Enriquez-Vera D, Beltran BE, et al
   Outcomes of CHOP versus CHOEP/EPOCH in aggressive adult T-cell leukemia/lymphoma: an international cohort analysis.
   Haematologica. 2026 Sep 10. doi: 10.3324/haematol.2026.300969.
   

   >> Share

   
   
4. SZMYD B, Wypyszczak K, Miarka-Walczyk K, Urbanska Z, et al
   Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients.
   Haematologica. 2026 Sep 10. doi: 10.3324/haematol.2026.301073.
   

   >> Share

   
   
5. SALZMANN RJS, Elia C, Carraro E, Pillon M, et al
   Prognostic value of plasma thymus- and activationregulated chemokine levels after the second cycle of chemotherapy in pediatric Hodgkin lymphoma.
   Haematologica. 2026 Sep 10. doi: 10.3324/haematol.2026.301490.
   

   >> Share

   
   
6. BARRETT A, Wang Z, McGale P, Broggio J, et al
   Age, anthracycline and mortality in 28,000 classic Hodgkin lymphoma patients: cohort study of a complete population.
   Haematologica. 2026 Sep 10. doi: 10.3324/haematol.2026.301079.
   

   >> Share

   
   

   
   Hum Pathol

7. WEISSFERDT A, Medeiros LJ, Moran CA
   Thymic hyperplasia with lymphoepithelial sialadenitis-like features A single-institution series of 21 new cases.
   Hum Pathol. 2026;176:106191.
   

   >> Share

   
   

   
   Int J Cancer

8. CHENG M, Li W, Liu M, Zou L, et al
   Bispecific Antibody-Based Combination Therapies for B-Cell Lymphomas: Current Evidence and Future Perspectives.
   Int J Cancer. 2026;159:2111-2126.
   

   >> Share

   
   

   
   J Clin Oncol

9. TUMULURU S, Cooper A, Jiang Y, Batlevi CL, et al
   LymphGen-Sig: Integrating Genetic and Transcriptional States to Predict Therapeutic Response in Diffuse Large B-Cell Lymphoma.
   J Clin Oncol. 2026 Sep 9:JCO2600451. doi: 10.1200/JCO-26-00451.
   

   >> Share

   
   

   
   Leuk Lymphoma

10. IZUMI K, Iwamoto R, Yano M, Ueda Y, et al
    Usefulness of 20-mm incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma: a single-center experience.
    Leuk Lymphoma. 2026 Sep 12:1-7. doi: 10.1080/10428194.2026.2731271.
    

    >> Share

    
    
11. TARANTELLI C, Civanelli E, Spriano F, Risi G, et al
    Surface expression of ROR1 across lymphoma cell lines identifies models for preclinical evaluation of ROR1-targeting antibody-drug conjugates.
    Leuk Lymphoma. 2026 Sep 7:1-4. doi: 10.1080/10428194.2026.2724722.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share